THURSDAY, Jan. 9, 2025 -- The outcomes of intensive versus standard blood pressure (BP) control seen in the Systolic Blood Pressure Intervention Trial...
Vous n'êtes pas connecté
THURSDAY, Jan. 9, 2025 -- The outcomes of intensive versus standard blood pressure (BP) control seen in the Systolic Blood Pressure Intervention Trial (SPRINT) are transportable to trial-eligible chronic kidney disease (CKD) patients from clinical...
THURSDAY, Jan. 9, 2025 -- The outcomes of intensive versus standard blood pressure (BP) control seen in the Systolic Blood Pressure Intervention Trial...
Mineralys Therapeutics, Inc., a clinical─stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney...
THURSDAY, Jan. 9, 2025 -- Smoking behavior seems to not have a causal effect on chronic kidney disease (CKD) risk in White individuals, according to a...
FRIDAY, Jan. 3, 2025 -- For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical...
FRIDAY, Jan. 3, 2025 -- For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical...
MONDAY, Jan. 6, 2025 -- Gestational exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk for childhood...
A recent study questions the smoking-CKD link, highlighting the role of other health factors.
A recent study published in Health Data Science led by Zhilong Zhang from the Institute of Medical Technology at Peking University Health Science...
MONDAY, Jan. 6, 2025 -- In a clinical practice guideline issued by the Alzheimer's Association and published online Dec. 23 in Alzheimer's &...
THURSDAY, Jan. 2, 2025 -- Disease-modifying therapy (DMT) use for multiple sclerosis (MS) in pregnancy is associated with certain adverse outcomes,...